
    
      A Dose Finding and Phase II Study of Selumetinib (AZD6244) (Hyd-Sulfate) in Combination with
      Irinotecan, in 2nd Line Patients with K-ras or B-raf Mutation Positive Advanced or Metastatic
      Colorectal Cancer
    
  